Edwards et al. linked EPHA2 overexpression with metastatic disease and dismal prognosis [45] and Youngblood et al. the overexpression of its phosphorylated form (pS897) with shorter survival in patients that present with lymph node metastases [46]. This evidence concerns the gene EPHA2 and metastatic neoplasm.